Bombay Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 07-12-2024
- Paid Up Capital ₹ 0.15 M
as on 07-12-2024
- Company Age 6 Year, 5 Months
- Last Filing with ROC 31 Mar 2021
About Bombay Lifesciences
The Company is engaged in the Service Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.15 M, as per Ministry of Corporate Affairs (MCA) records.
Pravin Jain, Jigyesh Patel, and Nidhi Kedar serve as directors at the Company.
- CIN/LLPIN
U93000MH2018PTC311349
- Company No.
311349
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jun 2018
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Bombay Lifesciences Private Limited offer?
Bombay Lifesciences Private Limited offers a wide range of products and services, including Common Disease Medicines, Pharmaceutical Medicine, Pain Relief Drugs & Pharmaceuticals, Osteoporosis Medications, Anti Infective Drugs & Medicines, HIV Drugs, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Sexual Wellness Products, Fertility Enhancer.
Who are the key members and board of directors at Bombay Lifesciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pravin Jain  | Director | 29-Jun-2018 | Current |
| Jigyesh Patel | Director | 29-Jun-2018 | Current |
| Nidhi Kedar | Director | 29-Jun-2018 | Current |
Financial Performance of Bombay Lifesciences.
Bombay Lifesciences Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Bombay Lifesciences?
Unlock access to Bombay Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bombay Lifesciences?
Unlock and access historical data on people associated with Bombay Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bombay Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bombay Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
